Fs Development Holdings, LLC is > 10% Shareholder of Gemini Therapeutics, Inc. . Currently has a direct ownership of 2.93 Million shares of GMTX, which is worth approximately $71.4 Million. The most recent transaction as insider was on Feb 05, 2021, when has been sold 2,928,750 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.93M
0% 3M change
0% 12M change
Total Value Held $71.4 Million

FS Development Holdings, LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 05 2021
Conversion of derivative security
2,928,750 Added 50.0%
2,928,750 Common Stock
Feb 05 2021
Grant, award, or other acquisition
$15,000,000 $10.0 p/Share
1,500,000 Added 50.0%
1,500,000 Common Stock
Aug 14 2020
Open market or private purchase
$4,415,000 $10.0 p/Share
441,500 Added 50.0%
441,500 Class A Common Stock

Fs Development Holdings, LLC

> 10% Shareholder
San Francisco, CA

Track Institutional and Insider Activities on GMTX

Follow Gemini Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GMTX shares.

Notify only if

Insider Trading

Get notified when an Gemini Therapeutics, Inc. insider buys or sells GMTX shares.

Notify only if


Receive news related to Gemini Therapeutics, Inc.

Track Activities on GMTX